BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Myriad Genetics, Inc. 

320 Wakara Way

Salt Lake City  Utah  84108  U.S.A.
Phone: 801-584-3600 Fax: 801-584-3640


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Myriad Genetics, Inc. (MYGN) myPath™ Melanoma Test Reduced Indeterminate Cases By 76 Percent And Changed Treatment In 35 Percent Of Cases 9/9/2014 10:47:54 AM
Myriad Genetics, Inc. (MYGN) Mypath™ Melanoma Test Reduced Indeterminate Cases By 76 Percent And Changed Treatment In 35 Percent Of Cases 9/9/2014 7:55:37 AM
Myriad Genetics, Inc. (MYGN) Publishes myRisk Hereditary Cancer Study In Cancer 9/4/2014 7:52:03 AM
Myriad Genetics, Inc. (MYGN) To Present At The Morgan Stanley (MST) Healthcare Conference 8/28/2014 7:20:52 AM
Myriad Genetics, Inc. (MYGN) Reports Fiscal Fourth-Quarter And Full-Year 2014 Financial Results 8/12/2014 3:28:54 PM
Myriad Genetics, Inc. (MYGN) To Announce Financial Results For The Fiscal Fourth Quarter And Full Year 2014 On August 12, 2014 7/30/2014 12:22:20 PM
Pathway Genomics Corporation Responds To Myriad Genetics, Inc. (MYGN) Lawsuit, Defends The Rights Of All Women To Receive BRCA Testing Regardless Of Socioeconomic Status 6/16/2014 10:33:55 AM
Myriad Genetics, Inc. (MYGN) Announces Retirement Of James Evans, Chief Financial Officer 6/10/2014 9:25:47 AM
Myriad Genetics, Inc. (MYGN) To Present At The Goldman, Sachs & Co. Global Healthcare Conference 6/3/2014 9:15:02 AM
Myriad Genetics, Inc. (MYGN) myPath™Melanoma Test Improves The Reliability Of Melanoma Diagnosis 6/2/2014 9:34:02 AM
12345678910...